122 related articles for article (PubMed ID: 1908001)
1. Effect of polymyxin B on experimental shock from meningococcal and Escherichia coli endotoxins.
Baldwin G; Alpert G; Caputo GL; Baskin M; Parsonnet J; Gillis ZA; Thompson C; Siber GR; Fleisher GR
J Infect Dis; 1991 Sep; 164(3):542-9. PubMed ID: 1908001
[TBL] [Abstract][Full Text] [Related]
2. Limulus antilipopolysaccharide factor protects rabbits from meningococcal endotoxin shock.
Alpert G; Baldwin G; Thompson C; Wainwright N; Novitsky TJ; Gillis Z; Parsonnet J; Fleisher GR; Siber GR
J Infect Dis; 1992 Mar; 165(3):494-500. PubMed ID: 1538154
[TBL] [Abstract][Full Text] [Related]
3. Oral Administration of Polymyxin B Modulates the Activity of Lipooligosaccharide E. coli B against Lung Metastases in Murine Tumor Models.
Kicielińska J; Szczygieł A; Rossowska J; Anger N; Kempińska K; Świtalska M; Kaszowska M; Wietrzyk J; Boratyński J; Pajtasz-Piasecka E
PLoS One; 2016; 11(2):e0148156. PubMed ID: 26829479
[TBL] [Abstract][Full Text] [Related]
4. Effect of meningococcal endotoxin in a rabbit model of shock.
Caputo GL; Baldwin G; Alpert G; Parsonnet J; Gillis ZA; Siber G; Fleisher G
Circ Shock; 1992 Feb; 36(2):104-12. PubMed ID: 1582001
[TBL] [Abstract][Full Text] [Related]
5. Effect of a human immunoglobulin preparation for intravenous use in a rabbit model of meningococcal endotoxin-induced shock.
Saladino R; Baldwin G; Alpert G; Parsonnet J; Gillis Z; Thompson C; Siber G; Fleisher G
Crit Care Med; 1992 Jun; 20(6):816-22. PubMed ID: 1597037
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock.
Hwang YH; Park BK; Lim JH; Kim MS; Park SC; Hwang MH; Yun HI
Eur J Pharmacol; 2007 Feb; 556(1-3):166-71. PubMed ID: 17126323
[TBL] [Abstract][Full Text] [Related]
7. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes.
Brandtzaeg P; Osnes L; Ovstebø R; Joø GB; Westvik AB; Kierulf P
J Exp Med; 1996 Jul; 184(1):51-60. PubMed ID: 8691149
[TBL] [Abstract][Full Text] [Related]
8. Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits.
Garcia C; Saladino R; Thompson C; Hammer B; Parsonnet J; Wainwright N; Novitsky T; Fleisher GR; Siber G
Crit Care Med; 1994 Aug; 22(8):1211-8. PubMed ID: 8045139
[TBL] [Abstract][Full Text] [Related]
9. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
Giacometti A; Cirioni O; Ghiselli R; Orlando F; Kamysz W; Rocchi M; D'Amato G; Mocchegiani F; Silvestri C; Łukasiak J; Saba V; Scalise G
Peptides; 2005 Feb; 26(2):207-16. PubMed ID: 15629532
[TBL] [Abstract][Full Text] [Related]
10. Polymyxin B moderates acidosis and hypotension in established, experimental gram-negative septicemia.
Flynn PM; Shenep JL; Stokes DC; Fairclough D; Hildner WK
J Infect Dis; 1987 Nov; 156(5):706-12. PubMed ID: 2821123
[TBL] [Abstract][Full Text] [Related]
11. Polymyxin B sulfate modification of bacterial endotoxin: effects on the development of endotoxin shock in dogs.
From AH; Fong JS; Good RA
Infect Immun; 1979 Mar; 23(3):660-4. PubMed ID: 222676
[TBL] [Abstract][Full Text] [Related]
12. Polymyxin-B inhibition of LPS-induced interleukin-1 secretion by human monocytes is dependent upon the LPS origin.
Cavaillon JM; Haeffner-Cavaillon N
Mol Immunol; 1986 Sep; 23(9):965-9. PubMed ID: 3023974
[TBL] [Abstract][Full Text] [Related]
13. Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy.
Brandtzaeg P; Bryn K; Kierulf P; Ovstebø R; Namork E; Aase B; Jantzen E
J Clin Invest; 1992 Mar; 89(3):816-23. PubMed ID: 1541674
[TBL] [Abstract][Full Text] [Related]
14. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C concentrate for the treatment of meningococcal endotoxin shock in rabbits.
Roback MG; Stack AM; Thompson C; Brugnara C; Schwarz HP; Saladino RA
Shock; 1998 Feb; 9(2):138-42. PubMed ID: 9488260
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia.
Bucklin SE; Lake P; Lögdberg L; Morrison DC
Antimicrob Agents Chemother; 1995 Jul; 39(7):1462-6. PubMed ID: 7492086
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of polymyxin B sulfate in experimental meningococcal infection in mice.
Bannatyne RM; Harnett NM; Cheung R
Can J Microbiol; 1977 Nov; 23(11):1526-8. PubMed ID: 200329
[TBL] [Abstract][Full Text] [Related]
18. Reduction of endotoxin-induced vascular permeability by monoclonal antibodies against lipopolysaccharide determinants.
Rubin RM; Noland J; Rosenbaum JT
Circ Shock; 1992 Mar; 36(3):217-23. PubMed ID: 1377103
[TBL] [Abstract][Full Text] [Related]
19.
Brusletto BS; Hellerud BC; Øvstebø R; Brandtzaeg P
Front Cell Infect Microbiol; 2023; 13():1298360. PubMed ID: 38089821
[TBL] [Abstract][Full Text] [Related]
20. Interaction of antimicrobial peptide s-thanatin with lipopolysaccharide in vitro and in an experimental mouse model of septic shock caused by a multidrug-resistant clinical isolate of Escherichia coli.
Wu G; Fan X; Li L; Wang H; Ding J; Hongbin W; Zhao R; Gou L; Shen Z; Xi T
Int J Antimicrob Agents; 2010 Mar; 35(3):250-4. PubMed ID: 20045294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
